-Responsible for assigned territory to regularly meet doctors for generating prescription.
-Maintain and develop relations with existing and new Doctors through appropriate propositions and sales methods.
-Implement of product promotion strategy and Company strategy.
-Liaison with the dealers, retailers and stockiest for servicing dates and answering queries.
-Ensuring the availability of product range with chemist & stockiest.
-Business generation through effective marketing strategy.
1. Should be working in Cardiac/ Diabetic Therapy or should be handling Hypertensive range of product in current Portfolio.
2. Should have covered Cardiologist/ Diabetic / Endocrinologist in Ahmedabad.
3. Should be having age not more than 28 Years
4. Should be a Science Graduate. (B.Sc, B.Pharm, D Pharm).
Salary: Not Disclosed by Recruiter
Industry: Pharma / Biotech / Clinical Research
Functional Area: Sales, Retail, Business Development
Role Category: Retail Sales
Role: Medical Representative
Employment Type: Permanent Job, Full Time
Sales Medico Marketing
Desired Candidate Profile
Doctorate – Doctorate Not Required
Cadila Healthcare Limited
Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the field of healthcare, Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.
The group launched Exemptia, the world’s first biosimilar for Adalimumab, the largest selling therapy worldwide for inflammatory arthritis. Zydus is also the only Indian pharma company to launch its own patented NCE – Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.
From a turnover of Rs. 250 crores in 1995, the group posted revenues of over Rs. 9800 crores in FY16. The group had posted a turnover of Rs. 4600 crores in FY 11, making it a billion dollar company. Today, Zydus Cadila holds a commanding position in the domestic pharma industry sweepstakes. The group has built strong positions in key segments of Cardiovasculars, Gastrointestinals, Women’s Healthcare and holds leading positions in other therapeutic segments such as Respiratory, Pain Management and Anti-infectives. Globally, the group has a strong presence in the regulated markets of the US, Europe (France & Spain) and the high profile markets of Latin America and South Africa. It also has a strong presence in 25 other emerging markets worldwide.
The group employs over 19,000 people worldwide and is dedicated to creating healthier communities globally. As a leading healthcare provider, it aims to become a global research based pharmaceutical company by 2020.